← Back to Search

Procedure

Halo laser for Alopecia

Phase < 1
Waitlist Available
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No evidence of spontaneous hair growth
Must be between the ages of 18 to 90 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

This trial is being done to see if fractional photothermolysis using different lasers can help stimulate hair growth in people with scalp alopecia.

Who is the study for?
This trial is for people aged 18 to 90 with alopecia on the scalp, specifically at the frontal hairline. Participants should be in good health, have not received other hair loss treatments in the past month, and must commit to following the study protocol. Those with a healthy scalp without tumors are eligible; both scarring and non-scarring alopecia are acceptable.Check my eligibility
What is being tested?
The study tests fractional photothermolysis (laser resurfacing) using two types of lasers: Fraxel DUAL 1550 or Halo by Sciton. It aims to stimulate hair growth through skin rejuvenation. Fifty subjects will receive treatment up to ten times over several weeks, with one side of their head treated and the other as control.See study design
What are the potential side effects?
Fractional laser treatment may cause minor side effects such as redness, swelling, heat sensation or discomfort at the site of application. The procedure involves heating skin tissue which can lead to rapid cell death but usually heals quickly with few adverse effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have not experienced any unexpected hair regrowth.
Select...
I am between 18 and 90 years old.
Select...
I have been diagnosed with scalp hair loss by a dermatologist.
Select...
My scalp is healthy and cancer-free.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hair regrowth by dermoscopy
Hair regrowth by optical coherence tomography (OCT).
Secondary outcome measures
Hair regrowth impact on Quality of Life

Trial Design

2Treatment groups
Experimental Treatment
Group I: Halo Hybrid Laser 1550 nmExperimental Treatment1 Intervention
The Halo laser will be used per protocol due to the dynamic thermal optimization technology for hair regrowth. 25 patients with alopecia will be part of this group.
Group II: Fraxel DUAL 1550 nmExperimental Treatment1 Intervention
The Fraxel DUAL 1550 nm laser will be used at 7 mJ, 8 pulses, 120 spots/cm2, treatment level 3 (9% coverage) for hair regrowth. 25 patients with alopecia will be part of this group.

Find a Location

Who is running the clinical trial?

Beckman Laser InstituteUNKNOWN
University of California, IrvineLead Sponsor
545 Previous Clinical Trials
1,923,061 Total Patients Enrolled
1 Trials studying Alopecia
30 Patients Enrolled for Alopecia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Fractional Photothermolysis for Hair Follicle Induction
Natasha Mesinkovska 2017. "Fractional Photothermolysis for Hair Follicle Induction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03382184.
All > Androgenetic Alopecia > Alopecia
~14 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top